GSK R&D Expenses
GSK plc American Depositary Shares (Each representing two Ordinary Shares) · R&D Expenses
GSK R&D Expenses
Latest reported£9.20B GBPperiod ending
GSK R&D Expenses · GBP (£113.00M → £9.20B)
Annual R&D Expenses
High-resolution chart · PNG
GSK r&d expenses history
Annual fiscal periods · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (GBP) |
|---|---|
| 7,525,000,000 | |
| 6,401,000,000 | |
| 6,223,000,000 | |
| 5,488,000,000 | |
| 5,019,000,000 | |
| 4,793,000,000 | |
| 4,568,000,000 | |
| 3,893,000,000 | |
| 4,476,000,000 | |
| 3,628,000,000 | |
| 3,560,000,000 | |
| 3,450,000,000 | |
| 3,923,000,000 | |
| 3,979,000,000 | |
| 4,009,000,000 | |
| 4,457,000,000 | |
| 4,106,000,000 | |
| 3,681,000,000 | |
| 3,240,311,000 | |
| 3,455,986,000 | |
| 3,135,358,000 | |
| 2,902,932,000 | |
| 2,787,120,000 | |
| 2,900,000,000 | |
| 2,560,904,000 | |
| 2,526,000,000 | |
| 1,269,000,000 | |
| 1,163,000,000 | |
| 1,148,000,000 | |
| 1,161,000,000 | |
| 1,540,000,000 | |
| 0 | |
| 858,000,000 | |
| 739,000,000 | |
| 595,000,000 | |
| 475,000,000 | |
| 420,000,000 | |
| 323,000,000 | |
| 230,000,000 | |
| 149,000,000 | |
| 113,000,000 |